Francesco Maria Lavino

CCO
GENETICS
 Novartis
Viet Nam

Academician Molecular Biology
Biography

The last half of his career has been focused on anti-infective medications administered primarily in the hospital setting. He most recently served as AVP, Global Brand Leader Anti-Infective Portfolio at Merck & Co. Inc. (known as MSD outside the United States), where he was responsible for the development and implementation of the global marketing strategy for the whole Merck anti-bacterial portfolio

Research Intrest

drug development